News | January 5, 2017

Arvinas Appoints Dr. John Houston as President of Research and Development and Chief Scientific Officer NEW HAVEN, Conn., January 5, 2017 – Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, today announced that it...

News | January 9, 2017

Intarcia and Calibr Announce Collaboration and In-Licensing Deal Aimed at Delivering a Next Generation Combination Product for Diabetes and Obesity Collaboration aims to develop a novel peptide therapeutic derived from Calibr’s Stapled-Peptide Technology Platform that...

News | January 4, 2017

Piedmont Healthcare Selects Kyruus’ Suite of Patient-Provider Matching Solutions by Kyruus, on Jan 4, 2017 9:37:03 AM BOSTON, MA – Kyruus, a leader in provider search and scheduling solutions for health systems, announced today that Piedmont Healthcare, a...
dolor. leo nunc Praesent Donec quis,